Search Results - "Herman, James G."

Refine Results
  1. 1

    Analysis of DNA methylation in cancer: location revisited by Koch, Alexander, Joosten, Sophie C., Feng, Zheng, de Ruijter, Tim C., Draht, Muriel X., Melotte, Veerle, Smits, Kim M., Veeck, Jurgen, Herman, James G., Van Neste, Leander, Van Criekinge, Wim, De Meyer, Tim, van Engeland, Manon

    Published in Nature reviews. Clinical oncology (01-07-2018)
    “…Changes in DNA methylation in cancer have been heralded as promising targets for the development of powerful diagnostic, prognostic, and predictive biomarkers…”
    Get full text
    Journal Article
  2. 2

    Epigenetic heterogeneity in cancer by Guo, Mingzhou, Peng, Yaojun, Gao, Aiai, Du, Chen, Herman, James G

    Published in Biomarker research (31-10-2019)
    “…Abstract Phenotypic and functional heterogeneity is one of the hallmarks of human cancers. Tumor genotype variations among tumors within different patients are…”
    Get full text
    Journal Article
  3. 3

    Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum by Hulbert, Alicia, Jusue-Torres, Ignacio, Stark, Alejandro, Chen, Chen, Rodgers, Kristen, Lee, Beverly, Griffin, Candace, Yang, Andrew, Huang, Peng, Wrangle, John, Belinsky, Steven A, Wang, Tza-Huei, Yang, Stephen C, Baylin, Stephen B, Brock, Malcolm V, Herman, James G

    Published in Clinical cancer research (15-04-2017)
    “…CT screening can reduce death from lung cancer. We sought to improve the diagnostic accuracy of lung cancer screening using ultrasensitive methods and a lung…”
    Get full text
    Journal Article
  4. 4

    Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer by Du, Wushuang, Gao, Aiai, Herman, James G., Wang, Lidong, Zhang, Lirong, Jiao, Shunchang, Guo, Mingzhou

    Published in Cancer science (01-07-2021)
    “…Wnt, PI3K‐Akt‐mTOR, and NF‐κB pathways were reported to be involved in DNA damage repair (DDR). DDR‐deficient cancers become critically dependent on backup DNA…”
    Get full text
    Journal Article
  5. 5

    Colorectal Cancer Epigenetics: Complex Simplicity by VAN ENGELAND, Manon, DERKS, Sarah, SMITS, Kim M, MEIJER, GerritA, HERMAN, James G

    Published in Journal of clinical oncology (01-04-2011)
    “…Colorectal cancer (CRC) has predominantly been considered a genetic disease, characterized by sequential accumulation of genetic alterations. Growing evidence…”
    Get full text
    Journal Article
  6. 6

    DNA-methylation for the detection and distinction of 19 human malignancies by Danilova, Ludmila, Wrangle, John, Herman, James G., Cope, Leslie

    Published in Epigenetics (01-02-2022)
    “…The contribution of DNA-methylation based gene silencing to carcinogenesis is well established. Increasingly, DNA-methylation is examined using genome-wide…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer by Singh, Anju, Misra, Vikas, Thimmulappa, Rajesh K, Lee, Hannah, Ames, Stephen, Hoque, Mohammad O, Herman, James G, Baylin, Stephen B, Sidransky, David, Gabrielson, Edward, Brock, Malcolm V, Biswal, Shyam

    Published in PLoS medicine (01-10-2006)
    “…Nuclear factor erythroid-2 related factor 2 (NRF2) is a redox-sensitive transcription factor that positively regulates the expression of genes encoding…”
    Get full text
    Journal Article
  9. 9

    GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer by Pelosof, Lorraine, Yerram, Sashidhar, Armstrong, Todd, Chu, Nina, Danilova, Ludmila, Yanagisawa, Breann, Hidalgo, Manuel, Azad, Nilofer, Herman, James G.

    Published in Epigenetics (03-07-2017)
    “…Epigenetic control of gene expression is a major determinant of tumor phenotype and has been found to influence sensitivity to individual chemotherapeutic…”
    Get full text
    Journal Article
  10. 10

    DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer by Brock, Malcolm V, Hooker, Craig M, Ota-Machida, Emi, Han, Yu, Guo, Mingzhou, Ames, Stephen, Glöckner, Sabine, Piantadosi, Steven, Gabrielson, Edward, Pridham, Genevieve, Pelosky, Kristen, Belinsky, Steven A, Yang, Stephen C, Baylin, Stephen B, Herman, James G

    Published in The New England journal of medicine (13-03-2008)
    “…Methylation of the promoter region of a gene is a mechanism that influences gene expression. In this study of patients with stage I non–small-cell lung cancer…”
    Get full text
    Journal Article
  11. 11

    The CpG Island Methylator Phenotype: What's in a Name? by HUGHES, Laura A. E, MELOTTE, Veerle, VAN CRIEKINGE, Wim, AHUJA, Nita, HERMAN, James G, WEIJENBERG, Matty P, VAN ENGELAND, Manon, DE SCHRIJVER, Joachim, DE MAAT, Michiel, SMIT, Vincent T. H. B. M, BOVEE, Judith V. M. G, FRENCH, Pim J, VAN DEN BRANDT, Piet A, SCHOUTEN, Leo J, DE MEYER, Tim

    Published in Cancer research (Chicago, Ill.) (01-10-2013)
    “…Although the CpG island methylator phenotype (CIMP) was first identified and has been most extensively studied in colorectal cancer, the term "CIMP" has been…”
    Get full text
    Journal Article
  12. 12

    Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling by Yang, Weili, Guo, Chao, Herman, James G, Zhu, Cheng, Lv, Honghui, Su, Xiaomo, Zhang, Lirong, Zhang, Meiying, Guo, Mingzhou

    Published in Clinical epigenetics (02-12-2022)
    “…The role of JAM3 in different tumors is controversial. The epigenetic regulation and the mechanism of JAM3 remain to be elucidated in human esophageal cancer…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence by Volonte, Daniela, Vyas, Avani R., Chen, Chen, Dacic, Sanja, Stabile, Laura P., Kurland, Brenda F., Abberbock, Shira R., Burns, Timothy F., Herman, James G., Di, Yuanpu Peter, Galbiati, Ferruccio

    Published in The Journal of biological chemistry (02-02-2018)
    “…Oncogene-induced senescence (OIS) is considered a powerful tumor suppressor mechanism. Caveolin-1 acts as a scaffolding protein to functionally regulate…”
    Get full text
    Journal Article
  15. 15

    The Epigenetic promise for prostate cancer diagnosis by Van Neste, Leander, Herman, James G, Otto, Gaëtan, Bigley, Joseph W, Epstein, Jonathan I, Van Criekinge, Wim

    Published in The Prostate (01-08-2012)
    “…BACKGROUND Prostate cancer is the most common cancer diagnosis in men and a leading cause of death. Improvements in disease management would have a significant…”
    Get full text
    Journal Article
  16. 16

    Predictive value of CHFR and MLH1 methylation in human gastric cancer by Li, Yazhuo, Yang, Yunsheng, Lu, Youyong, Herman, James G., Brock, Malcolm V., Zhao, Po, Guo, Mingzhou

    “…Background Gastric carcinoma (GC) has one of the highest mortality rates of cancer diseases and has a high incidence rate in China. Palliative chemotherapy is…”
    Get full text
    Journal Article
  17. 17

    DREAMing: a simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies by Pisanic, 2nd, Thomas R, Athamanolap, Pornpat, Poh, Weijie, Chen, Chen, Hulbert, Alicia, Brock, Malcolm V, Herman, James G, Wang, Tza-Huei

    Published in Nucleic acids research (15-12-2015)
    “…Many cancers comprise heterogeneous populations of cells at primary and metastatic sites throughout the body. The presence or emergence of distinct subclones…”
    Get full text
    Journal Article
  18. 18

    Neighborhood-level deprivation and survival in lung cancer by Kennedy, Kathleen, Jusue-Torres, Ignacio, Buller, Ian D, Rossi, Emily, Mallisetty, Apurva, Rodgers, Kristen, Lee, Beverly, Menchaca, Martha, Pasquinelli, Mary, Nguyen, Ryan H, Weinberg, Frank, Rubinstein, Israel, Herman, James G, Brock, Malcolm, Feldman, Lawrence, Aldrich, Melinda C, Hulbert, Alicia

    Published in BMC cancer (06-08-2024)
    “…Despite recent advances in lung cancer therapeutics and improving overall survival, disparities persist among socially disadvantaged populations. This study…”
    Get full text
    Journal Article
  19. 19

    Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling by Cao, Baoping, Yang, Weili, Jin, Yongshuai, Zhang, Meiying, He, Tao, Zhan, Qimin, Herman, James G, Zhong, Guanglin, Guo, Mingzhou

    Published in Journal of thoracic oncology (01-11-2016)
    “…Naked cuticle homolog 2 (NKD2) was found to be frequently methylated in human breast and gastric cancers. However, the epigenetic changes and mechanisms of…”
    Get more information
    Journal Article
  20. 20

    hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site by ZINN, Rebekah L, PRUITT, Kevin, EGUCHI, Sayaka, BAYLIN, Stephen B, HERMAN, James G

    Published in Cancer research (Chicago, Ill.) (2007)
    “…hTERT, which encodes the catalytic subunit of telomerase and is expressed in most immortalized and cancer cells, has been reported to have increased DNA…”
    Get full text
    Journal Article